"KRAS G12D is a predictive biomarker for several therapies, including afatinib, dacomitinib, erlotinib, gefitinib, osimertinib, cetuximab, and panitumumab."
https://www.mycancergenome.org/content/alteration/kras-g12d/
all these cant use/ doenst work?